Hyaluronan-Cyclodextrin Conjugates as Doxorubicin Delivery Systems.

CD44 SK-N-SH cyclodextrins doxorubicin hyaluronan-cyclodextrin conjugate hyaluronic acid nanomedicine nanoparticles

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
21 Jan 2023
Historique:
received: 20 12 2022
revised: 16 01 2023
accepted: 18 01 2023
entrez: 25 2 2023
pubmed: 26 2 2023
medline: 26 2 2023
Statut: epublish

Résumé

In the last years, nanoparticles based on cyclodextrins have been widely investigated for the delivery of anticancer drugs. In this work, we synthesized nanoparticles with a hyaluronic acid backbone functionalized with cyclodextrins under green conditions. We functionalized hyaluronic acid with two different molecular weights (about 11 kDa and 45 kDa) to compare their behavior as doxorubicin delivery systems. We found that the new hyaluronan-cyclodextrin conjugates increased the water solubility of doxorubicin. Moreover, we tested the antiproliferative activity of doxorubicin in the presence of the new cyclodextrin polymers in SK-N-SH and SK-N-SH-PMA (over-expressing CD44 receptor) cancer cells. We found that hyaluronan-cyclodextrin conjugates improved the uptake and antiproliferative activity of doxorubicin in the SK-N-SH-PMA compared to the SK-N-SH cell line at the ratio 8/1 doxorubicin/polymer. Notably, the system based on hyaluronan (45 kDa) was more effective as a drug carrier and significantly reduced the IC

Identifiants

pubmed: 36839696
pii: pharmaceutics15020374
doi: 10.3390/pharmaceutics15020374
pmc: PMC9963997
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Polymers (Basel). 2022 Aug 23;14(17):
pubmed: 36080515
Chemistry. 2013 Oct 4;19(41):13946-55
pubmed: 24038335
Colloids Surf B Biointerfaces. 2016 Nov 1;147:281-290
pubmed: 27522557
Photochem Photobiol Sci. 2013 Oct;12(10):1841-54
pubmed: 23900688
Carbohydr Polym. 2013 Sep 12;97(2):635-42
pubmed: 23911495
Front Immunol. 2015 Jun 02;6:261
pubmed: 26082778
Int J Pharm. 2018 Jan 15;535(1-2):272-284
pubmed: 29138045
Front Cell Dev Biol. 2017 Mar 07;5:18
pubmed: 28326306
Cancer. 2017 Dec 15;123(24):4914-4923
pubmed: 28885700
Biomater Adv. 2022 Feb;133:112623
pubmed: 35525766
Pharmaceutics. 2022 Aug 22;14(8):
pubmed: 36015374
Future Oncol. 2020 Apr;16(11):687-700
pubmed: 32253930
Drug Deliv. 2018 Nov;25(1):766-772
pubmed: 29536778
Nat Commun. 2021 Feb 3;12(1):759
pubmed: 33536421
Chem Rev. 1997 Aug 5;97(5):1325-1358
pubmed: 11851454
Int J Pharm. 2020 Nov 15;589:119879
pubmed: 32931844
J Mater Chem B. 2022 Mar 30;10(13):2077-2096
pubmed: 35233592
Biomaterials. 2016 Sep;101:10-9
pubmed: 27262027
ACS Appl Mater Interfaces. 2018 Oct 24;10(42):35693-35704
pubmed: 30259743
Macromol Rapid Commun. 2019 Jan;40(1):e1800557
pubmed: 30216584
J Biomed Mater Res A. 2008 Dec 15;87(4):1044-52
pubmed: 18257063
Cancer Res. 1997 Apr 1;57(7):1387-93
pubmed: 9102228
Life Sci. 2021 Aug 1;278:119527
pubmed: 33887349
Invest New Drugs. 2018 Jun;36(3):370-379
pubmed: 29116478
J Drug Target. 2015;23(7-8):605-18
pubmed: 26453158
Invest New Drugs. 2017 Oct;35(5):539-544
pubmed: 28378257
Carbohydr Polym. 2017 Oct 1;173:37-49
pubmed: 28732878
Int J Pharm. 2021 Jun 1;602:120602
pubmed: 33862128
Molecules. 2014 Mar 17;19(3):3193-230
pubmed: 24642908
Sci Rep. 2016 Feb 12;6:20923
pubmed: 26868174
J Control Release. 2012 Jun 10;160(2):117-34
pubmed: 22484195
Chemistry. 2017 Mar 28;23(18):4442-4449
pubmed: 28150894
J Control Release. 2021 Aug 10;336:598-620
pubmed: 34237401
Pharmaceutics. 2021 Dec 10;13(12):
pubmed: 34959412
Biochem J. 1991 Mar 15;274 ( Pt 3):699-705
pubmed: 2012600
Carbohydr Polym. 2021 Nov 15;272:118491
pubmed: 34420747
Nat Nanotechnol. 2021 Nov;16(11):1180-1194
pubmed: 34759355
Drug Discov Today. 2015 Sep;20(9):1120-6
pubmed: 26037681
Molecules. 2021 Oct 06;26(19):
pubmed: 34641590
Sci Rep. 2017 Nov 17;7(1):15811
pubmed: 29150635
Chem Soc Rev. 2017 Jul 17;46(14):4218-4244
pubmed: 28585944
Adv Pharm Bull. 2020 Jun;10(2):166-183
pubmed: 32373486
Invest New Drugs. 2019 Aug;37(4):771-778
pubmed: 30556100
Macromol Biosci. 2014 Mar;14(3):327-33
pubmed: 24130147

Auteurs

Noemi Bognanni (N)

Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Viale A. Doria 6, 95125 Catania, Italy.

Maurizio Viale (M)

UOC Bioterapie, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132 Genova, Italy.

Luana La Piana (L)

Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Viale A. Doria 6, 95125 Catania, Italy.

Simone Strano (S)

Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Viale A. Doria 6, 95125 Catania, Italy.

Rosaria Gangemi (R)

UOC Bioterapie, IRCCS Ospedale Policlinico San Martino, Largo R. Benzi 10, 16132 Genova, Italy.

Cinzia Lombardo (C)

Dipartimento di Scienze Biomediche e Biotecnologiche, Sezione di Biochimica Medica, Università degli Studi di Catania, Via S. Sofia 97, 95125 Catania, Italy.

Maria Teresa Cambria (MT)

Dipartimento di Scienze Biomediche e Biotecnologiche, Sezione di Biochimica Medica, Università degli Studi di Catania, Via S. Sofia 97, 95125 Catania, Italy.

Graziella Vecchio (G)

Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Viale A. Doria 6, 95125 Catania, Italy.

Classifications MeSH